|
|
Article: 3rd Annual Pharma & Biotech Business Intelligence Summit September 18-19 in Princeton, N.J. Asks: Is CI Still CI?
- Article from:
- PR Newswire
- Article date:
- July 29, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEW YORK, July 29 /PRNewswire/ -- The growing importance of competitive intelligence within the pharmaceutical and biotech industries will be the focus at the 3rd Annual Pharma & Biotech Business Intelligence Summit, to be held this year in Princeton, N.J. on September 18-19 (http://www.srinstitute.com/cm416).
The very nature of business intelligence -- of competitive intelligence -- has continued to expand and evolve, increasingly moving beyond its narrow origin to become a vital key to corporate strategic decision making within the pharmaceutical and biotech arena. In fact, CI has evolved to the point where it is fair to ask: Is CI Still CI?
The ...